Abstract
To evaluate the utilization of monotherapy second-generation antidepressants for treating depression among adults in the US based on patients’ characteristics. Also, to investigate the association between second-generation antidepressant utilization and visits to mental health professionals. METHOD: A cross-sectional secondary data analysis using the National Health and Nutrition Examination Survey database from 2013-2018. The study participants included adults aged above 19 years, diagnosed with depression, and were taking only one of the second-generation antidepressants approved by 2013.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
